**Study Overview**: This study is looking at how safe and effective a medicine called **Elfabrio®** is for people with **Fabry disease**, a rare genetic condition that affects how your body handles fat. The study is observational, which means doctors will watch and record details about patients who are already taking Elfabrio® as part of their regular care. **Who Can Join**: To be part of the study, you need to be over 18, have a confirmed diagnosis of Fabry disease, and either be taking or planning to take Elfabrio®. You also need to agree to be part of the study and complete some surveys. Some specific heart tests, like a **cardiac magnetic resonance imaging (cMRI)**, are also part of the study. **Key Points**: - **Length**: This is an ongoing study, and participants will be involved for an unspecified period as part of their regular treatment. - **Visits**: Regular medical visits are needed, where doctors will monitor your health and record data. - **Compensation**: There's no mention of payment, but participation may help improve future treatment for Fabry disease. Please consider if you meet these conditions and are comfortable with the study's requirements before deciding to participate.